» Articles » PMID: 33949666

Effectiveness of Influenza Vaccines in the HIVE Household Cohort Over 8 Years: Is There Evidence of Indirect Protection?

Overview
Journal Clin Infect Dis
Date 2021 May 5
PMID 33949666
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The evidence that influenza vaccination programs regularly provide protection to unvaccinated individuals (ie, indirect effects) of a community is lacking. We sought to determine the direct, indirect, and total effects of influenza vaccine in the Household Influenza Vaccine Evaluation (HIVE) cohort.

Methods: Using longitudinal data from the HIVE cohort from 2010-11 through 2017-18, we estimated direct, indirect, and total influenza vaccine effectiveness (VE) and the incidence rate ratio of influenza virus infection using adjusted mixed-effect Poisson regression models. Total effectiveness was determined through comparison of vaccinated members of full or partially vaccinated households to unvaccinated individuals in completely unvaccinated households.

Results: The pooled, direct VE against any influenza was 30.2% (14.0-43.4). Direct VE was higher for influenza A/H1N1 43.9% (3.9 to 63.5) and B 46.7% (17.2 to 57.5) than A/H3N2 31.7% (10.5 to 47.8) and was higher for young children 42.4% (10.1 to 63.0) than adults 18.6% (-6.3 to 37.7). Influenza incidence was highest in completely unvaccinated households (10.6 per 100 person-seasons) and lower at all other levels of household vaccination coverage. We found little evidence of indirect VE after adjusting for potential confounders. Total VE was 56.4% (30.1-72.9) in low coverage, 43.2% (19.5-59.9) in moderate coverage, and 33.0% (12.1 to 49.0) in fully vaccinated households.

Conclusions: Influenza vaccines may have a benefit above and beyond the direct effect but that effect in this study was small. Although there may be exceptions, the goal of global vaccine recommendations should remain focused on provision of documented, direct protection to those vaccinated.

Citing Articles

Influenza virus shedding and symptoms: Dynamics and implications from a multiseason household transmission study.

Morris S, Nguyen H, Grijalva C, Hanson K, Zhu Y, Biddle J PNAS Nexus. 2024; 3(9):pgae338.

PMID: 39246667 PMC: 11378077. DOI: 10.1093/pnasnexus/pgae338.


Respiratory Viral Infections from 2015 to 2022 in the HIVE Cohort of American Households: Incidence, illness characteristics, and seasonality.

Monto A, Foster-Tucker J, Callear A, Leis A, Godonou E, Smith M J Infect Dis. 2024; .

PMID: 39179953 PMC: 11847950. DOI: 10.1093/infdis/jiae423.


Respiratory virus circulation during the first year of the COVID-19 pandemic in the Household Influenza Vaccine Evaluation (HIVE) cohort.

Fine S, Bazzi L, Callear A, Petrie J, Malosh R, Foster-Tucker J Influenza Other Respir Viruses. 2023; 17(3):e13106.

PMID: 36875204 PMC: 9975790. DOI: 10.1111/irv.13106.


Influenza.

Uyeki T, Hui D, Zambon M, Wentworth D, Monto A Lancet. 2022; 400(10353):693-706.

PMID: 36030813 PMC: 9411419. DOI: 10.1016/S0140-6736(22)00982-5.


The Nicaraguan Pediatric Influenza Cohort Study, 2011-2019: Influenza Incidence, Seasonality, and Transmission.

Maier H, Kuan G, Gresh L, Chowell G, Bakker K, Lopez R Clin Infect Dis. 2022; 76(3):e1094-e1103.

PMID: 35639580 PMC: 10169406. DOI: 10.1093/cid/ciac420.

References
1.
Ohmit S, Petrie J, Malosh R, Cowling B, Thompson M, Shay D . Influenza vaccine effectiveness in the community and the household. Clin Infect Dis. 2013; 56(10):1363-9. PMC: 3693492. DOI: 10.1093/cid/cit060. View

2.
Heikkinen T . Influenza in children. Acta Paediatr. 2006; 95(7):778-84. DOI: 10.1080/08035250600612272. View

3.
Worby C, Chaves S, Wallinga J, Lipsitch M, Finelli L, Goldstein E . On the relative role of different age groups in influenza epidemics. Epidemics. 2015; 13:10-16. PMC: 4469206. DOI: 10.1016/j.epidem.2015.04.003. View

4.
Rolfes M, Foppa I, Garg S, Flannery B, Brammer L, Singleton J . Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness. Influenza Other Respir Viruses. 2018; 12(1):132-137. PMC: 5818346. DOI: 10.1111/irv.12486. View

5.
Arinaminpathy N, Kim I, Gargiullo P, Haber M, Foppa I, Gambhir M . Estimating Direct and Indirect Protective Effect of Influenza Vaccination in the United States. Am J Epidemiol. 2017; 186(1):92-100. PMC: 5860220. DOI: 10.1093/aje/kwx037. View